One-glance verdict
Fair value unavailable
Not enough cash-flow history to value this one with our method.
Fundamentals snapshot
HYPR · NGM · Healthcare · Medical Devices
Current price
$0.93
52-week range
$0.75 - $2.22
Market cap
$98.70M
One-glance verdict
Not enough cash-flow history to value this one with our method.
Balance sheet
Net cash $30.05M. Interest coverage shows how many times profit covers the interest bill.
What stands out
What this company does
Hyperfine, Inc. makes portable MRI machines that are smaller and less powerful than typical ones, helping doctors see inside patients' bodies for things like strokes or head injuries. They make money by selling these machines, offering support services, and providing a cloud system to store and view images (this is where most of their revenue comes from). This matters because it means they can reach more hospitals and clinics, especially in places that can't afford or fit larger MRI equipment.
-100 ## Hyperfine, Inc. Explainer ### How the company got here Hyperfine, Inc. was founded in 2014 by Dr. Jonathan Rothberg, a serial entrepreneur known for creating innovative healthcare and technology companies. The company's origin story is rooted in a desire to make magnetic resonance imaging (MRI) more accessible and affordable, aiming to save lives by bringing this crucial diagnostic tool closer to patients, regardless of their location. A key turning point was the development and subsequent FDA clearance of their flagship product, the Swoop Portable MR Imaging System, which marked a significant advancement in medical technology by offering a portable MRI solution. This innovation positioned Hyperfine as a pioneer in the field of point-of-care diagnostics. ### What it actually does Hyperfine develops and commercializes portable Magnetic Resonance Imaging (MRI) systems. Their primary product, the Swoop system, is a compact MRI machine that can be wheeled directly to a patient's bedside. Unlike traditional, large MRI machines that require a dedicated room and specialized infrastructure, the Swoop system is designed for simplicity and can be plugged into a standard electrical outlet. It uses artificial intelligence (AI) to produce images of the brain and head, enabling healthcare professionals to make faster diagnostic decisions in various clinical settings. ### Swoop Portable MR Imaging System This is Hyperfine's core business and currently its only distinct business line. The Swoop system is a portable, ultra-low-field MRI device designed to image the brain and head. It's particularly useful in situations where transporting a patient to a traditional MRI scanner is difficult or impossible, such as in intensive care units (ICUs), emergency departments, or even in remote locations. The system's portability and ease of use allow for quicker diagnoses, potentially leading to faster treatment and better patient outcomes. Hyperfine generates revenue by selling these Swoop systems and related services to hospitals, clinics, and other healthcare facilities. The company is actively working to improve the image quality of the Swoop system through AI advancements and software updates, aiming to make it a more comprehensive diagnostic tool. ### What management is betting on now Hyperfine's management is focused on expanding the reach and utility of its Swoop system. A key strategic priority is to move the technology into new care settings, such as emergency departments and neurology offices, beyond its current stronghold in critical care units. They are also heavily investing in research and development (R&D) to continuously improve the AI-powered software and imaging capabilities of the Swoop system, aiming to enhance image quality and secure FDA clearances for new clinical applications. International expansion is another significant focus, with the company actively seeking distribution partners in new global markets to increase worldwide access to their portable MRI technology.
Price history
Earnings history
Click any quarter to read the call summary and what the numbers say.
Is it cheap or expensive?
We couldn't calculate a fair value right now.
Is it drowning in debt?
Net cash $30.0M - more cash than debt. Interest coverage -36.3x.
Hyperfine, Inc. is healthier than 0 of 1 peers on balance-sheet leverage.
Total debt $13.41M Interest coverage -36.25x This is the baseline the peer rows are being compared against.
What you should know
The numbers
Tap any ? icon to learn what it means.
Valuation
Profitability
Health
Growth
Cash flow
Dividend
Metric explainer
Debt comparison
What you should know